Skip to content

Evaluation of the effect of Lemon Balm/ Star anice in treatment of COVID-19 patients as well as their prophylactic effects in close contacts with COVID-19 patients

Evaluation of the effect of Lemon Balm/ Star anice in treatment of COVID-19 patients as well as their prophylactic effects in close contacts with COVID-19 patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150902023864N2
Enrollment
120
Registered
2021-02-08
Start date
2021-01-20
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group 1: Lemon Balm capsule (Manobrain, Rahman Daroo)- Twice per day. Intervention 2: Intervention group 2: Star Anice capsule (Manoflo- Rahman daroo)- Twice per day. Inte

Sponsors

Rahman Gostaran
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Prophylactic study: Those who live with a Covid-19 patient in a single house. Prophylactic study: Have not had Covid-19 (or its symptoms) so far. Prophylactic study: Maximum 7 days have passed since start of Covid-19 symptoms Treatment study: Covid-19 patients Treatment study: Maximum 7 days have passed since start of Covid-19 symptoms. Treatment study: Have not taken anti-virus drugs in the last 14 days

Exclusion criteria

Exclusion criteria: pregnant/ breast feeding women Underlying diseases heprsensitivity to herbal drug used in this study or their derivatives use of antiviral drugs in the last 2 weeks use of immune suppressor medicine use of serotonin inhibitor or othee sedative medicines

Design outcomes

Primary

MeasureTime frame
Prophylactic study: clinical/lab confirmation of the disease. Timepoint: weekly. Method of measurement: examination- PCR test.;Prophylactic study: hospitalization due to Covid-19. Timepoint: weekly. Method of measurement: Hospital report.;Treatment study: general state of patient. Timepoint: weekly. Method of measurement: examination.;Treatment study: hospitalization due to Covid-19. Timepoint: weekly. Method of measurement: Hospital report.;Treatment study: death due to Covid-19. Timepoint: weekly. Method of measurement: Hospital report.;Prophylactic study: death due to Covid-19. Timepoint: weekly. Method of measurement: hospital report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Amani

Bojnourd University of Medical Sciences

amani76@gmail.com+98 21 3229 7182

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026